Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiuzhi Zhu
Observed names:
X. Zhu,
Xiu-Zhi Zhu
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Zhejiang Chinese Medical University,
Shanghai Medical College of Fudan University,
Shandong University,
Fudan University,
Fudan University Shanghai Cancer Center,
Weifang People's Hospital
show all 6
ORCID:
0000-0001-8369-3161
Observed ORCID:
0000-0001-8369-3161
OpenAlex ID:
A5101507830
MiR-134 modulates chronic stress-induced structural plasticity and depression-like behaviors via downregulation of Limk1/cofilin signaling in rats
2018
·
Cuiqin Fan
, Xiuzhi Zhu
, et al.
·
Neuropharmacology
·
65
Stability and variability of molecular subtypes: comparative analysis of primary and metastatic triple-negative breast cancer
2024
·
Xiuzhi Zhu
, Xiaohan Ying
, et al.
·
Cancer Biology and Medicine
·
11
Risk Factors for Gastric Cancer‐Associated Thrombotic Diseases in a Han Chinese Population
2021
·
Bo Song
, Yamei Wang
, et al.
·
BioMed Research International
·
8
PDF
[Pathogenesis and clinical significance of interleukin-8 and tumor necrosis factor-alpha in cervicitis].
2009
·
Yu-Mei Ning
, Yin Wang
, et al.
·
PubMed
·
2
Abstract PS4-39: Efficacy of combined CDK4/6 inhibitor and PARP inhibitor in the treatment of BRCA1 mutant triple negative breast cancer
2021
·
Xiuzhi Zhu
, Li Chen
, et al.
·
Cancer Research
·
1
20 Disease-specific Survival in Men With Interval Cancers Compared to Men With Cancers in the Control Arm: Long-term Results of the European Randomized Study of Screening for Prostate Cancer (erspc)
2011
·
X. Zhu
, P.J. Van Leeuwen
, et al.
·
European Urology Supplements
·
1
Comprehensive genomic profiling of triple-negative breast cancer metastases identifies role of PKD1 in immunotherapy resistance
2026
·
Xiu-Zhi Zhu
, Yi-Fan Zhou
, et al.
·
Journal of Clinical Investigation
PDF
Abstract PS3-01: Tislelizumab plus sitravatinib and nab-paclitaxel in patients with untreated locally recurrent or metastatic triple negative breast cancer (TNBC): updated efficacy and safety results
2025
·
Xiyu Liu
, Ying Xu
, et al.
·
Clinical Cancer Research
Tratuzumab deruxtecan: A real-world study in the treatment of metastatic breast cancer in China.
2025
·
Kunyu Zhang
, Xiuzhi Zhu
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
9
Citation count:
88
H-index:
3
I10-index:
2
Year
Topic
Type